Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1995
10/11/1995EP0675893A1 Anticonvulsant sorbopyranose sulfamates
10/11/1995EP0675888A1 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor
10/11/1995EP0675886A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
10/11/1995EP0675883A1 Piperidine derivatives as calcium channel antagonists
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675717A1 Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an anti-depressant drug
10/11/1995EP0440704B1 Compositions for treating tobacco withdrawel symptoms
10/11/1995CN1110057A Tricyclic defem sulphones as elastase inhibitors
10/11/1995CN1109880A 3-(2-aminoethyl)-4-|3-(trifluoromethyl) benzoyl¨-3,4-dihydro-1,4-benzoxazine derivative and preparation of same
10/11/1995CN1109875A Phenyl-substituted 1,4-dihydropyridines
10/11/1995CN1109874A Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine3,5-dicarboxylate
10/11/1995CN1109870A N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application of same
10/11/1995CN1109775A "Shuibituo" soporific
10/11/1995CN1109774A Medicated wine composition for curing sciatica
10/11/1995CN1109750A Methods of inhibiting the effects of amyloidogenic proteins
10/11/1995CN1109745A Ibuprofen-containing solid composition
10/11/1995CN1029972C Selective adenosine receptor compounds
10/11/1995CN1029968C Process for preparation of N-heteroaryl-purin-6-amines and their use as medicaments
10/11/1995CN1029963C Thiazine or oxazine derivatives and preparation thereof
10/11/1995CN1029960C Neuroprotective 3-piperidino-4-hydroxychroman derivatives
10/10/1995US5457273 Processing Waste solidification
10/10/1995US5457212 Resolution of a thienopyran derivative using methylbenzyl isocyanate; nitration
10/10/1995US5457133 Treating Parkinson's disease, memory disorders, Alzheimer's disease, depression and hyperactive syndrome
10/10/1995US5457129 Inhibition of nitric oxide production by retinoic acid
10/10/1995US5457110 Apioid analgesic without respiratory depression
10/10/1995US5457109 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
10/10/1995US5457034 Vectors for expression of NGF in eukaryotic cells
10/09/1995CA2146600A1 Products with antiglucocorticoid activity used for preparing drugs intended for the prevention or the treatment of manifestations caused by a spontaneous or a precipitated withdrawal symptom due to narcotics or mixtures of narcotics; compositions containing the same
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995026352A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026351A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026350A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same
10/05/1995WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026344A1 Sesquiterpenic derivatives
10/05/1995WO1995026342A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026339A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
10/05/1995WO1995026328A1 Biphenyl derivatives as 5ht1d antagonists
10/05/1995WO1995026327A1 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists
10/05/1995WO1995026187A1 Anxiolytic agent
10/05/1995DE4411225A1 Verwendung von Carbonsäurederivaten als Arzneimittel The use of carboxylic acid derivatives as medicaments
10/05/1995CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
10/05/1995CA2184754A1 5h-indeno[1,2-b]pyrazine-2,3-dione derivatives, preparation thereof and drugs containing same
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/04/1995EP0675118A2 Biphenylderivatives, process for their preparation and their use as medicaments
10/04/1995EP0675103A2 Derivatives of essential fatty acids and nonsteroidal antiinflammatory drugs
10/04/1995EP0674660A1 Multifunctional neurotrophic factors
10/04/1995EP0674642A1 Pyrazolopyrimidines as crf antagonists
10/04/1995EP0674641A1 Pyrrolopyrimidines as crf antagonists
10/04/1995EP0674633A1 Benzopyran derivatives
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/04/1995EP0674631A1 Substituted pyrazoles as crf antagonists
10/04/1995EP0674625A1 Amino-substituted pyrazoles having crf antagonistic activity
10/04/1995EP0674624A1 Pyrazoles and pyrazolopyrimidines having crf antagonist activity
10/04/1995EP0674622A1 Tetrahydrocarbazole derivatives as 5-ht1-like agonists
10/04/1995EP0674621A1 Enantiomers of carbazole derivatives as 5-ht1-like agonists
10/04/1995EP0674620A1 Tryptamine analogues as 5-ht 1?-like agonists
10/04/1995EP0674619A1 Tryptamine analogues as 5-ht 1?-like agonists
10/04/1995EP0674527A1 Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
10/04/1995EP0674520A1 Application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries
10/04/1995EP0674519A1 Potassium channel activators and use thereof in therapy
10/04/1995EP0674518A1 Application of lamotrigine in the treatment of neurological lesions related to traumatic injuries
10/04/1995EP0674517A1 Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen
10/04/1995EP0674514A1 Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives
10/04/1995EP0674512A1 Application of riluzole in the treatment of neurological lesions related to traumatic injuries
10/04/1995EP0674509A1 Methods for treatment with dimercaptosuccinic acid (dmsa)
10/04/1995EP0618905B1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
10/04/1995CN1109335A Medicine for curing mental disease and its preparing method
10/04/1995CN1109331A Methods of inhibiting obsessive-compulsive and consumptive disorders
10/03/1995US5455354 Contacting ether-substituted starting material with aluminum chloride, hydrobromic acid or boron tribromide followed by tartaric acid to form hydroxy compound, contacting with carbonyldimidazole in presence of acid, reacting with amine
10/03/1995US5455252 Optionally substituted 6,8-quinolines
10/03/1995US5455250 Treating central nervous system disorders
10/03/1995US5455246 Treating neuropsychiatric disorders
10/03/1995CA1337201C 4,5,6,7-tetrahydroisothiazolo [4,5-c] pyridine derivatives
10/03/1995CA1337199C Five-membered ring systems with bonded azacyclic ring substituents
10/03/1995CA1337195C 4,5,7,8-tetrahydro-6h-thiazolo[5,4-d]azepines, their preparation and their use as pharmaceuticals
10/03/1995CA1337193C Muscarinic receptor antagonists
09/1995
09/30/1995CA2144669A1 Biphenyl derivatives
09/28/1995WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
09/28/1995WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
09/28/1995WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF)
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/28/1995WO1995025792A1 Neuron promoter and uses
09/28/1995WO1995025736A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
09/28/1995WO1995025733A1 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
09/28/1995WO1995025732A1 N-p-HALOBENZOYLMETHYL DERIVATIVES OF 4-(p-FLUOROPHENYL)-3-((3,4-METHYLENE-DIOXY)PHENOXY)METHYL)PIPERIDINE
09/28/1995WO1995025727A1 Naphthylamides as central nervous system agents
09/28/1995WO1995025721A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025535A1 Thyroxin-binding proteins
09/28/1995WO1995025533A1 PROTEASOME REGULATION OF NF-λB ACTIVITY
09/28/1995WO1995025531A1 Means for treating auto-immune diseases and method of treatment
09/28/1995WO1995025509A2 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
09/28/1995DE4410822A1 Neue Piperidin-Derivate New piperidine derivatives
09/28/1995CA2186035A1 Thyroxin-binding proteins
09/28/1995CA2186010A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995CA2185892A1 Means for treating auto-immune diseases and method of treatment
09/28/1995CA2185813A1 Vitamin-d amide derivatives
1 ... 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 ... 1833